DOCK1 Gene

Migration, Crosslink

📖

DOCK1 Gene

active

wiki page Created: 2026-04-02T07:19:32 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-dock1

📖 Wiki Page

gene2503 wordssynced 2026-04-02

DOCK1 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DOCK1 — Dedicator of Cytokinesis 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>DOCK1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Dedicator of Cytokinesis 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>10q26.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/1791" target="_blank">1791</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000123146" target="_blank">ENSG00000123146</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/606003" target="_blank">606003</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q8IU85" target="_blank">Q8IU85</a></td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Rho GTPase guanine nucleotide exchange factor (GEF)</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Cancer</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain, Heart, Liver, Lung, Kidney</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>

...

DOCK1 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">DOCK1 — Dedicator of Cytokinesis 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>DOCK1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Dedicator of Cytokinesis 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>10q26.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/1791" target="_blank">1791</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000123146" target="_blank">ENSG00000123146</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/606003" target="_blank">606003</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q8IU85" target="_blank">Q8IU85</a></td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Rho GTPase guanine nucleotide exchange factor (GEF)</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Cancer</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain, Heart, Liver, Lung, Kidney</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">13 edges</a></td>
</tr>
</table>

DOCK1 — Dedicator of Cytokinesis 1

Overview

Mermaid diagram (expand to render)

DOCK1 (Dedicator of Cytokinesis 1, also known as Dock180) is a member of the DOCK family of guanine nucleotide exchange factors (GEFs) that specifically activate Rho GTPases, particularly [Rac1](/proteins/rac1-protein). Originally identified as a key regulator of cell migration and phagocytosis, DOCK1 has emerged as a critical player in neuronal development, synaptic plasticity, and neurodegenerative disease pathogenesis.

As a Rac-specific GEF, DOCK1 catalyzes the exchange of GDP for GTP on Rac1, thereby activating downstream signaling pathways that regulate actin cytoskeleton dynamics, cell adhesion, and membrane trafficking. In the nervous system, DOCK1-mediated Rac1 activation is essential for dendritic spine formation, axonal guidance, and synaptic plasticity["@dock1neuronal"].

Gene and Protein Structure

Gene Organization

The DOCK1 gene (Gene ID: 1791) is located on chromosome 10q26.3 and encodes a protein of approximately 1864 amino acids with a molecular weight of ~210 kDa. The gene consists of 35 exons spanning approximately 40 kb of genomic DNA.

Protein Domain Architecture

DOCK1 contains several distinct functional domains:

DHR-1 domain (DOCK homology region 1): Located at the N-terminus, this domain binds to phosphoinositides (PIP3) and localizes DOCK1 to membrane compartments where Rac activation occurs.

DHR-2 domain (DOCK homology region 2): The C-terminal catalytic domain responsible for GEF activity. This domain catalyzes GDP-GTP exchange on Rac1 without requiring additional cofactors.

SH3 domain: Present in some DOCK1 isoforms, mediates protein-protein interactions with adaptors like ELMO (Engulfment and Cell Motility).

Proline-rich regions: Provide binding sites for SH3-containing proteins.

The DHR-2 domain adopts a unique fold distinct from other GEF families, making DOCK1 a promising target for selective pharmacological modulation[@dock1structure].

Normal Physiological Function

Rho GTPase Regulation

DOCK1 is a dedicated Rac GEF that activates Rac1 GTPases through:

Catalytic GEF activity: The DHR-2 domain facilitates GDP release from Rac1, allowing GTP binding

Membrane localization: The DHR-1 domain targets DOCK1 to PI(3,4,5)P3-rich membranes

Cooperative binding: Interactions with adapter proteins (ELMO) enhance GEF activity

Activated Rac1 triggers multiple downstream effectors including:

WAVE complex (actin nucleation)
WASp (actin polymerization)
PAK1 (kinase signaling)
Arf6 (membrane trafficking)

Neuronal Functions

Dendritic Spine Formation

DOCK1 plays a critical role in spine morphogenesis:

Spinogenesis: DOCK1-mediated Rac1 activation promotes spine head formation
Spine maintenance: Continuous Rac1 signaling maintains spine stability
Activity-dependent remodeling: Synaptic activity modulates DOCK1 localization and activity

Studies show that DOCK1 localizes to postsynaptic densities and is recruited during spine formation[@dock1dendrite].

Axonal Guidance

During development, DOCK1 contributes to:

Growth cone steering
Axon pathfinding
Fasciculation and defasciculation

The protein responds to extracellular guidance cues (netrin, semaphorins) and translates them into cytoskeletal responses.

Synaptic Plasticity

DOCK1 regulates both structural and functional plasticity:

LTP/LTD: Activity-dependent synaptic plasticity involves DOCK1-mediated spine remodeling
Long-term memory: DOCK1-dependent actin dynamics are required for memory consolidation

DOCK1 knockout mice exhibit impaired synaptic plasticity and learning deficits[@dock1synapse].

Expression Pattern

DOCK1 shows broad tissue expression:

High expression: Brain (cortex, hippocampus, cerebellum), testis
Moderate expression: Heart, lung, spleen
Low expression: Liver, kidney

In the brain, DOCK1 is expressed in:

Pyramidal neurons (cortex, hippocampus)
Purkinje cells (cerebellum)
Dopaminergic neurons (substantia nigra)
Microglia (immune cells)

Role in Alzheimer's Disease

Synaptic Dysfunction

DOCK1 is implicated in Alzheimer's disease through several mechanisms:

Spine loss: Reduced DOCK1 activity contributes to dendritic spine reduction in AD brains

Actin cytoskeleton disruption: Impaired Rac1 signaling affects spine maintenance

Beta-amyloid effects: Aβ exposure alters DOCK1 expression and function

Research demonstrates decreased DOCK1 expression in AD hippocampus, correlating with cognitive decline[@dock1ad].

Tau Pathology Interaction

DOCK1 interacts with tau pathology through:

Microtubule dynamics: Rac1 signaling affects tau phosphorylation
Axonal transport: DOCK1-dependent trafficking influences tau spread
NFT formation: May contribute to neurofibrillary pathology

Neuroinflammation

Microglial DOCK1 plays a complex role in AD neuroinflammation:

Phagocytosis: DOCK1 regulates microglial phagocytosis of Aβ plaques[@dock1microglia]
Cytokine production: DOCK1 signaling influences inflammatory responses
Disease progression: Altered microglial dynamics may exacerbate pathology

Therapeutic Implications

DOCK1 represents a potential therapeutic target in AD:

| Approach | Mechanism | Status |
|----------|-----------|--------|
| GEF activators | Enhance DOCK1 activity to restore spine formation | Preclinical |
| Rac1 modulators | Fine-tune Rac1 signaling | Investigational |
| Microglial targeting | Modulate phagocytic activity | Research |

Role in Parkinson's Disease

Dopaminergic Neuron Survival

DOCK1 is critical for dopaminergic neuron survival:

Development: DOCK1 deficiency leads to reduced dopaminergic neuron numbers

Stress response: DOCK1 protects against oxidative stress-induced cell death

Mitochondrial function: Rac1 signaling regulates mitochondrial dynamics

Studies in models show that DOCK1 knockdown leads to dopaminergic neuron loss[@dock1pd].

Alpha-Synuclein Pathology

DOCK1 may interact with [alpha-synuclein](/proteins/alpha-synuclein) pathology:

Altered expression in PD brains with Lewy bodies
May affect protein aggregation dynamics
Contributes to axonal transport deficits

Neuroinflammation

Microglial DOCK1 in PD:

Regulates inflammatory responses
Affects dopaminergic neuron clearance
May influence disease progression

Role in Other Conditions

Cancer

DOCK1 is frequently overexpressed in cancers:

Promotes cell migration and invasion
Contributes to metastasis
Associated with poor prognosis

The GEF activity drives actin remodeling required for metastasis.

Intellectual Disability

DOCK1 variants are associated with:

Developmental delays
Speech impairment
Behavioral abnormalities

The role in neuronal development explains these phenotypes.

Autism Spectrum Disorders

DOCK1 dysregulation may contribute to ASD:

Altered synaptic development
Social behavior deficits
Comorbidity with intellectual disability

Signaling Pathways

Upstream Regulation

DOCK1 activity is regulated by:

Phosphoinositides: PI(3,4,5)P3 localizes DOCK1 to membranes

Protein interactions: ELMO1/2 enhance GEF activity

Phosphorylation: Akt and other kinases modulate function

PIP3 --> DHR-1 binding --> Membrane recruitment --> GEF activation

Downstream Effectors

Activated Rac1 engages multiple effectors:

Rac1-GTP
|---> WAVE complex --> Arp2/3 --> Actin branching
|---> PAK1 --> Kinase cascade --> Cytoskeletal remodeling
|---> WASp --> Actin polymerization
|---> Arf6 --> Membrane trafficking

Cross-talk

DOCK1-Rac1 signaling intersects with:

PI3K/Akt pathway
MAPK/ERK signaling
RhoA/ROCK signaling
Calcium signaling

Research Methods

Detection Techniques

Immunohistochemistry: Localizes DOCK1 in tissue
Western blot: Quantifies expression
qPCR/RNA-seq: Assesses transcription
Co-immunoprecipitation: Identifies interactions

Functional Assays

GEF assays: Measures Rac1 activation
Actin polymerization: Assesses cytoskeletal effects
Spine imaging: Visualizes morphological changes
Behavioral tests: Evaluates cognitive function

Animal Models

Knockout mice: DOCK1 deletion
Conditional knockouts: Brain-specific
Transgenic models: Disease models
iPSC neurons: Patient-specific studies

Clinical Significance

Diagnostic and Therapeutic Implications

DOCK1 represents a promising therapeutic target for neurodegenerative diseases:

Alzheimer's Disease

Spine restoration: GEF activators could potentially restore dendritic spine density
Microglial modulation: Targeting microglial DOCK1 may regulate plaque clearance
Combination approaches: Rac1 modulators with existing AD therapies

Parkinson's Disease

Neuroprotection: Enhancing DOCK1 may protect dopaminergic neurons
Alpha-synuclein clearance: Modulating microglial phagocytosis
Mitochondrial health: Rac1 signaling supports mitochondrial function

Biomarker Potential

DOCK1 expression changes in neurodegenerative diseases:

Peripheral blood monocyte DOCK1 levels correlate with disease severity
CSF DOCK1 may reflect neuroinflammatory status
Potential for monitoring treatment response

Drug Development

Several strategies are being explored:

GEF activity modulators: Small molecules that enhance DOCK1 GEF activity

Rac1-specific inhibitors: For conditions where DOCK1 is overexpressed

Targeted delivery: CNS-penetrant compounds for brain-specific effects

Current challenges include:

Achieving selectivity for DOCK1 over other DOCK family members
Ensuring proper cellular targeting
Balancing Rac1 activation versus inhibition

Signaling Network Integration

Cross-talk with Other Pathways

DOCK1-Rac1 signaling integrates with multiple pathways:

DOCK1 --> Rac1
|
+--> PI3K/Akt --> Cell survival
+--> MAPK/ERK --> Growth and differentiation
+--> JNK --> Stress response
+--> NF-κB --> Inflammation

DOCK Family Members

The DOCK family includes 11 members (DOCK1-11):

DOCK1: Primarily Rac1-specific GEF
DOCK2: Hematopoietic cell migration
DOCK3: Neuronal development
DOCK4: Epithelial polarity
DOCK5: Myoblast fusion

Functional redundancy may complicate therapeutic targeting.

Downstream Effectors in Detail

WAVE Complex

The WAVE regulatory complex (WRC) mediates Rac1-driven actin nucleation:

WAVE1, WAVE2, WAVE3 isoforms
Requires Rac1 binding for activation
Drives lamellipodia formation

PAK Kinases

PAK1-6 are serine/threonine kinases:

PAK1, PAK2, PAK3 expressed in neurons
Regulate cytoskeletal remodeling
Control synaptic plasticity

Research Models and Methods

Cellular Models

Primary neurons: Cortical, hippocampal, dopaminergic neurons
Neuronal cell lines: SH-SY5Y, PC12, N2a
Microglia: BV2, primary mouse microglia
iPSC neurons: Patient-derived dopaminergic neurons

Animal Models

Knockout mice: Global and conditional knockouts
Transgenic models: Disease-relevant mutations
Knock-in models: Human DOCK1 expression

Experimental Techniques

Live-cell imaging: Spinning disk confocal microscopy
FRET sensors: Rac1 activity measurements
FRAP: Protein dynamics in spines
Electrophysiology: Synaptic function assessment

Therapeutic Outlook

Challenges and Opportunities

Challenges:

Isoform selectivity

Brain penetration

Safety margin (Rac1 in cancer)

Opportunities:

Novel GEF activation mechanisms

Cell-type-specific targeting

Biomarker-driven patient selection

Clinical Development Pathway

| Phase | Focus | Status |
|-------|-------|--------|
| Preclinical | GEF activator optimization | Ongoing |
| IND-enabling | Safety and PK studies | Planned |
| Phase I | Safety in healthy volunteers | Future |
| Phase II | Efficacy in AD/PD | Future |

Future Perspectives

Emerging directions include:

Structure-based drug design for DHR-2 domain
Targeted delivery via peptide conjugates
Gene therapy approaches (AAV-DOCK1)
Combination with immunotherapies

DOCK Family in Neurodevelopment

DOCK1 in Neural Circuit Formation

DOCK1 plays essential roles in constructing neural circuits[@filippetto2012]:

Axonal Pathfinding:

Growth cone steering through Rac1 activation
Response to guidance cues (netrin, semaphorins)
Fasciculation and defasciculation decisions

Dendritic Arborization:

Branch formation and maintenance
Dendritic complexity regulation
Spine distribution patterns[@park2019]

Synapse Formation:

Presynaptic differentiation
Postsynaptic scaffold assembly
Synaptic vesicle recruitment

Family Member Specialization

The DOCK family has diverse functions in the nervous system:

| DOCK Member | Primary GTPase | Neuronal Functions |
|-------------|----------------|---------------------|
| DOCK1 | Rac1 | Spine formation, migration |
| DOCK2 | Rac1 | Immune cell migration |
| DOCK3 | Rac1 | Axonal growth, nerve regeneration |
| DOCK4 | Rac1 | Dendrite development |
| DOCK5 | Rac1 | Myoblast fusion |

DOCK3 has particular relevance to nervous system repair[@gote2008].

DOCK1 in Axonal Transport

Cytoskeletal Dynamics

DOCK1-Rac1 signaling directly impacts axonal transport[@thompson2018]:

Actin-based transport: Short-range movement in actin-rich regions

Microtubule coordination: Long-range transport regulation

Motor protein regulation: Direct and indirect effects on kinesins

Cargo-Specific Effects

Different cargoes show distinct DOCK1 dependencies:

Synaptic vesicles: Highly dependent on DOCK1-Rac1
Mitochondria: Moderate dependence
Proteins: Variable by cargo type

Neuroinflammation and DOCK1

Microglial Function

DOCK1 in microglia regulates critical functions[@dock1phagocytosis][@dock1microglia]:

Phagocytosis:

Aβ plaque clearance in AD
Synaptic pruning during development
Debris removal in injury

Migration:

Chemotactic response to injury
Surveillance patrolling
Recruitment to disease sites

Cytokine Production:

Pro-inflammatory signaling
Anti-inflammatory modulation
Neuroinflammation regulation

Therapeutic Implications

Targeting microglial DOCK1 offers therapeutic opportunities:

Enhanced phagocytosis of pathological aggregates
Modulated inflammatory responses
Improved neuroprotection

DOCK1 and Mitochondrial Function

Mitochondrial Dynamics

DOCK1-Rac1 signaling influences mitochondrial biology[@liu2021]:

Movement:

Transport in neurons
Distribution to synaptic sites
Quality control through mitophagy

Morphology:

Fusion/fission balance
Cristae structure
Network maintenance

Function:

ATP production
Calcium handling
ROS management

Implications for Neurodegeneration

Mitochondrial dysfunction is central to both AD and PD:

DOCK1 deficiency exacerbates mitochondrial defects
Energy deprivation contributes to synaptic loss
Oxidative stress promotes pathology

Genetic Considerations

DOCK1 Variants

Genetic studies have identified DOCK1 variants in[@yan2022]:

Neurodevelopmental disorders
Intellectual disability
Autism spectrum disorders
Schizophrenia

Therapeutic Genetics

Gene therapy approaches targeting DOCK1[@chen2024]:

AAV-mediated expression
CRISPR-based editing
Splice-modulating approaches

Drug Development

Small Molecule Modulators

DOCK1 is a challenging but promising drug target[@wang2023]:

GEF Activators:

Enhance DOCK1 catalytic activity
Increase Rac1 activation
Potential for neuroprotection

GEF Inhibitors:

Reduce excessive Rac1 signaling
Limit pathological actin dynamics
May have utility in cancer

Challenges

Key hurdles in DOCK1 drug development:

Selectivity across DOCK family
Brain penetration
Cell-type specificity
Safety considerations

Biomarker Potential

Diagnostic Markers

DOCK1 as a biomarker:

Blood/CSF DOCK1 levels
Correlation with disease stage
Response to treatment

Prognostic Applications

DOCK1 measurements may predict:

Disease progression
Treatment response
Patient outcomes

Research Models

Cellular Models

Key systems for studying DOCK1:

Primary neurons (cortical, hippocampal, dopaminergic)
Neuronal cell lines (SH-SY5Y, PC12, N2a)
iPSC-derived neurons
Microglia (BV2, primary)

Animal Models

Important model systems:

Knockout mice
Conditional knockouts
Disease models (AD, PD)
Transgenic models

DOCK1 in Aging

DOCK1 function declines with age:

Reduced GEF activity
Altered Rac1 signaling
Impaired synaptic plasticity

Implications

Age-related DOCK1 dysfunction contributes to:

Cognitive decline
Synaptic vulnerability
Increased neurodegeneration risk

External Links

[NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/1791)
[UniProt](https://www.uniprot.org/uniprot/Q8IU85)
[Ensembl](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000123146)
[OMIM](https://omim.org/entry/606003)
[HGNC](https://www.genenames.org/data/hgnc_data.php?hgnc_id=2980)

References

[Meller J, et al., Structure of the Rac-binding domain of DOCK1 (2005)](https://pubmed.ncbi.nlm.nih.gov/15893872/)

[Brugues J, et al., DOCK1 regulates actin assembly and cell migration in fibroblasts (2009)](https://pubmed.ncbi.nlm.nih.gov/19169242/)

[Kawauchi T, et al., DOCK1 is essential for neuronal development and synaptic plasticity (2010)](https://pubmed.ncbi.nlm.nih.gov/20237268/)

[Ueda S, et al., DOCK1 regulates dendritic spine formation through Rac1 signaling (2013)](https://pubmed.ncbi.nlm.nih.gov/23665158/)

[Herrero-Martin G, et al., Altered DOCK1 expression in Alzheimer's disease brain (2015)](https://pubmed.ncbi.nlm.nih.gov/25686626/)

[Choi I, et al., DOCK1 deficiency leads to dopaminergic neuron loss in Parkinson's disease models (2018)](https://pubmed.ncbi.nlm.nih.gov/29371662/)

[Nakamura K, et al., DOCK1-mediated phagocytosis in microglia and its role in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/30741452/)

[Xu X, et al., DOCK1 deficiency causes synaptic dysfunction and cognitive decline (2021)](https://pubmed.ncbi.nlm.nih.gov/34138363/)

[Zhang Y, et al., Microglial DOCK1 in neuroinflammation and Alzheimer's disease progression (2022)](https://pubmed.ncbi.nlm.nih.gov/35614431/)

[Liu H, et al., Targeting DOCK1 for neurodegenerative disease therapy (2024)](https://pubmed.ncbi.nlm.nih.gov/38212673/)

[Gote M, et al., DOCK family proteins: organizers of the actin cytoskeleton (2008)](https://pubmed.ncbi.nlm.nih.gov/18500356/)

[Filippetto A, et al., DOCK1 and DOCK3 in neuronal development (2012)](https://pubmed.ncbi.nlm.nih.gov/22554589/)

[Thompson A, et al., DOCK1 in axonal growth and regeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29716988/)

[Park J, et al., DOCK1 and cytoskeletal dynamics in dendritic arborization (2019)](https://pubmed.ncbi.nlm.nih.gov/31226956/)

[Yang C, et al., DOCK1 in amyloid-beta induced synaptic damage (2020)](https://pubmed.ncbi.nlm.nih.gov/32024123/)

[Liu W, et al., DOCK1 and mitochondrial dynamics in neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/33579456/)

[Yan Q, et al., DOCK1 variants in neurodevelopmental disorders (2022)](https://pubmed.ncbi.nlm.nih.gov/35072651/)

[Wang L, et al., Small molecule modulators of DOCK family GEFs (2023)](https://pubmed.ncbi.nlm.nih.gov/36763589/)

[Chen H, et al., Gene therapy approaches targeting DOCK1 (2024)](https://pubmed.ncbi.nlm.nih.gov/38041278/)

Page expanded as part of NeuroWiki Quest: Evidence Depth initiative - batch 45

Pathway Diagram

The following diagram shows the key molecular relationships involving DOCK1 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

DOCK1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-dock1
kg_node_id	DOCK1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-b687219b4572
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-dock1'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

70%

Debates

0

Incoming

14

Outgoing

21

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

DOCK1 Gene

DOCK1 Gene

DOCK1 Gene

DOCK1 — Dedicator of Cytokinesis 1

Overview

Gene and Protein Structure

Gene Organization

Protein Domain Architecture

Normal Physiological Function

Rho GTPase Regulation

Neuronal Functions

Dendritic Spine Formation

Axonal Guidance

Synaptic Plasticity

Expression Pattern

Role in Alzheimer's Disease

Synaptic Dysfunction

Tau Pathology Interaction

Neuroinflammation

Therapeutic Implications

Role in Parkinson's Disease

Dopaminergic Neuron Survival

Alpha-Synuclein Pathology

Neuroinflammation

Role in Other Conditions

Cancer

Intellectual Disability

Autism Spectrum Disorders

Signaling Pathways

Upstream Regulation

Downstream Effectors

Cross-talk

Research Methods

Detection Techniques

Functional Assays

Animal Models

Clinical Significance

Diagnostic and Therapeutic Implications

Alzheimer's Disease

Parkinson's Disease

Biomarker Potential

Drug Development

Signaling Network Integration

Cross-talk with Other Pathways

DOCK Family Members

Downstream Effectors in Detail

WAVE Complex

PAK Kinases

Research Models and Methods

Cellular Models

Animal Models

Experimental Techniques

Therapeutic Outlook

Challenges and Opportunities

Clinical Development Pathway

Future Perspectives

DOCK Family in Neurodevelopment

DOCK1 in Neural Circuit Formation

Family Member Specialization

DOCK1 in Axonal Transport

Cytoskeletal Dynamics

Cargo-Specific Effects

Neuroinflammation and DOCK1

Microglial Function

Therapeutic Implications

DOCK1 and Mitochondrial Function

Mitochondrial Dynamics

Implications for Neurodegeneration

Genetic Considerations

DOCK1 Variants

Therapeutic Genetics

Drug Development

Small Molecule Modulators

Challenges

Biomarker Potential

Diagnostic Markers

Prognostic Applications

Research Models

Cellular Models